Skip to main content
Erschienen in: BMC Ophthalmology 1/2020

Open Access 01.12.2020 | Case report

Unusual non-nanophthalmic uveal effusion syndrome with histologically normal scleral architecture: a case report

verfasst von: Kasama Kaewsangthong, Somanus Thoongsuwan, Mongkol Uiprasertkul, Nopasak Phasukkijwatana

Erschienen in: BMC Ophthalmology | Ausgabe 1/2020

Abstract

Background

To report an unusual case of non-nanophthalmic uveal effusion syndrome (UES) with histologically normal sclera but responsive to scleral resection.

Case presentation

A73-year-old man presented with a bullous retinal detachment without ciliochoroidal detachment on funduscopic examination of the right eye. The axial length of both eyes was normal. Extensive investigations for possible causes of exudative retinal detachment were performed with unremarkable results except for choroidal hyperpermeability on indocyanine green angiography (ICGA). Ultrasound biomicroscopy (UBM) revealed scleral thickening with peripheral choroidal elevation leading to the diagnosis of UES.
Partial thickness sclerectomy and sclerotomy was performed resulting in complete retinal reattachment, reduction of choroidal hyperpermeability on ICGA and improvement of visual acuity. However, histological studies of the excised sclera revealed no scleral architectural changes or abnormal deposits.

Conclusions

The diagnosis of UES in non-nanophthalmic eyes is challenging. Thorough systemic and ocular investigations are critical to rule out other etiologies. UBM can be helpful to evaluate scleral thickness and anterior choroid in equivocal cases. Our case was unique in that, although the sclera was thick, no abnormal microscopic scleral architecture could be identified. Misdiagnosis may lead to different surgical procedures such as vitrectomy resulting in unfavorable outcomes.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
BCVA
Best-corrected visual acuity
FA
Fluorescein angiography
ICGA
Indocyanine green angiography
IOP
Intraocular pressure
UBM
Ultrasound biomicroscopy
UES
Uveal effusion syndrome

Background

Idiopathic uveal effusion or uveal effusion syndrome (UES) is an extremely rare disease and often associated with nanophthalmic eyes [1]. The pathogenesis is thought to be related to abnormal sclera causing impaired scleral permeability and/or vortex vein compression, which leads to fluid accumulation in the choroid, ciliochoroidal detachment and accompanying exudative retinal detachment [24].
We reported a diagnostic challenging case of idiopathic UES in a non-nanophthalmic eye presented with retinal detachment without ciliochoroidal detachment seen on clinical examination. Our case was unique in that, despite the thickened sclera, histological studies revealed no scleral architectural changes and surgical management with scleral resection and sclerotomy was successful.

Case presentation

A 73-year-old male presented with painless decreased visual acuity, floaters and flashes in the right eye for 2 weeks. The right eye did not have any previous history of trauma, surgery, cryotherapy or laser photocoagulation except for an uneventful cataract surgery 15 years ago. His left eye had undergone vitrectomy with retained silicone oil to treat retinal detachment for 8 months from another hospital. The left eye was now aphakic with retinal redetachment under the silicone oil, secondary glaucoma and band keratopathy. His medical underlying diseases were essential hypertension and hyperlipidemia. His systemic medications included amlodipine, losartan and simvastatin.
At presentation, best-corrected visual acuity (BCVA) was 0.6 logMAR and counting fingers in the right and left eyes, respectively. Intraocular pressure (IOP) was 14 mmHg in the right eye and 12 mmHg in the left eye. Ocular examination of the right eye showed normal conjunctiva and sclera, clear cornea, mildly shallow anterior chamber with no cell or flare and the eye was pseudophakic. The pupil was dilatable to 5 mm. Dilated fundus examination revealed corrugated inferior bullous retinal detachment with shifting of subretinal fluid (Fig. 1a). No definite choroidal detachment or a retinal break was identified with a wide-field contact lens. Optical coherence tomography (SPECTRALIS, Heidelberg Engineering, Heidelberg, Germany) of the macula showed subretinal fluid, a small juxtapapillary pigment epithelial detachment and intraretinal cysts (Fig. 2a and b). At this point, rhegmatogenous retinal detachment with a very small retinal break versus exudative retinal detachment were to be differentiated. The patient was then worked up for possible etiologies of exudative retinal detachment including choroidal inflammation, choroidal tumors and atypical central serous chorioretinopathy.
Ocular B-scan ultrasonography (Aviso, Quantel Medical, Clermont-Ferrand, France) demonstrated ocular wall thickening with peripheral choroidal elevation in the right eye. No tumors were identified and no subtenon fluid collection to suggest posterior scleritis was detected. The axial length measurement (IOL Master 500, Carl Zeiss Meditec, Jena, Germany) was 22.59 and 22.94 mm in the right and left eyes, respectively, which was not compatible with nanophthalmos. Fluorescein angiography (FA) (SPECTRALIS, Heidelberg Engineering) showed granular hyperfluorescence, consistent with window defects, at the mid-periphery and peripapillary areas. No dye leakage was detected to explain the subretinal fluid, which made central serous chorioretinopathy unlikely (Fig. 3). Indocyanine green angiography (ICGA) (SPECTRALIS, Heidelberg Engineering) demonstrated diffuse early hypercyanescence especially in the posterior pole and superotemporal vortex veins that persisted to the late phase in the peripapillary area (Fig. 4, column a). FA and ICGA showed no evidence of chorioretinal inflammation, which made choroiditis such as sympathetic ophthalmia unlikely. Blood tests including complete blood count, blood chemistries, erythrocyte sedimentation rate, C-reactive protein, serological test for human immunodeficiency virus, venereal disease research laboratory test for syphilis, Treponema pallidum haemagglutination test, interferon gamma assay for tuberculosis, antinuclear antibodies test and antineutrophil cytoplasmic antibodies test were all within normal limit. The chest x-ray was also performed and showed no pulmonary infiltration. After excluding the infectious etiologies, 1 mg/kg/day of oral systemic steroid was challenged to the patient for 7 days without clinical responses. UES was now high in the differential diagnosis. The ultrasound biomicroscopy (UBM) (Aviso, Quantel Medical) was then performed and revealed edematous thickening of the anterior choroid and thickening of the anterior sclera measuring up to 1.26 mm (Fig. 5), leading to the diagnosis of UES (normal scleral thickness at the corneoscleral limbus is 0.53 ± 0.14 mm [5]).
Partial thickness sclerectomy and sclerotomy was then performed based on the technique described by Gass, 1983 [6]. In brief, two-thirds thickness scleral flaps of 5 mm × 7 mm were created centering at 2 mm anterior to the equator in each of the 4 quadrants. Full thickness sclerotomy (scleral window) of 2 mm × 2 mm was then made on each of the remaining scleral beds under the flaps. The scleral flaps from inferonasal and inferotemporal quadrants were excised and sent for histological examination.
At 2-week post-operation, the BCVA improved to 0.2 logMAR in the right eye with the IOP of 16 mmHg and the subretinal fluid progressively reduced. At 4 months, the retina was completely attached, revealing a typical leopard spot pattern described in UES (Fig. 1b, 2c and d). One year after the surgery, follow-up ICGA revealed less choroidal hyperpermeability (Fig. 4, column b). Histologic findings (Fig. 6) of the excised sclera revealed neither inflammation nor disorganization of collagen fibers. Special stains including periodic acid–Schiff, periodic acid–Schiff–diastase, alcian blue, alcian blue with hyaluronidase, mucicarmine, congo red and reticulin showed no demonstrable proteoglycans or other abnormal substance deposits.

Discussion and conclusions

We reported a diagnostic challenging case of UES presented with exudative retinal detachment without detectable ciliochoroidal detachment on clinical examination in a normal axial length eye. We demonstrated that UBM was a simple method to evaluate the scleral thickness and the anterior choroid to guide the diagnosis of UES in ambiguous cases. Our case was also unique in that there were no microscopic architectural changes of the sclera despite multiple histochemical stains, although the sclera was thickened and the surgical management with partial thickness sclerectomy with sclerotomy was successful.
Histologic studies of the sclera of UES demonstrated that increased scleral thickness was due to accumulation of proteoglycans, especially dermatan sulphate and chondroitin sulphate, causing resistance to transscleral flow and accumulation of fluid in the suprachoroidal and subretinal space [7, 8]. A comprehensive review by Uyama et al. [8] classified patients with UES into three types. Type 1 is nanophthalmic (axial length less than 19 mm) with high-graded hypermetropia and thickened sclera. Type 2 also has thick sclera, but with normal axial length and unremarkable refractive error. Histological studies of the excised sclera in types 1 and 2 revealed disorganized collagen fibers and deposition of proteoglycans. In contrast, type 3 has normal axial length, normal scleral thickness and normal scleral histology. Scleral resection and sclerotomy was an effective treatment only in type 1 and 2. According to this classification, our case was most compatible with type 2 but without histologically abnormal collagen fibers or proteoglycans deposits. Our case also suggested an alternative mechanism of increased scleral thickness not involving proteoglycans deposition of the sclera.
The pathogenesis of UES may involve several hypotheses including vortex vein compression, reduced scleral protein permeability, reduced scleral hydraulic conductivity, chronic hypotony and increased choroidal permeability [9]. Interestingly, ICGA in our case showed choroidal hyperpermeability seen as intense early hypercyanescence in the posterior pole that persisted till the late phase. The hyperpermeability became less in the follow-up ICGA at 1 year after the surgery with complete resolution of the subretinal fluid (Fig. 4, column b). This suggested that increased choroidal permeablility also play a significant role of uveal effusion in this patient. Interplay of multiple factors including relatively thick sclera and increased choroidal permeability might predispose this patient to UES. In addition, we noticed a peculiar finding of abnormal peripapillary hypercyanescence in the very late (30 min) ICGA. It might be possible that, apart from vortex veins, choroidal venous drainage in this patient occurred slowly through choroidopial veins in the peripapillary region [10] leading to the very late peripapillary hypercyanescence, although the exact mechanism of this peculiar finding remains unknown.
In summary, UES is a diagnosis of exclusion especially in cases of non-nanophthalmic eyes. Thorough systemic investigations and multimodal retinal imaging are critical to rule out other etiologies. UBM, a simple noninvasive investigation, can be very helpful to evaluate scleral thickness and anterior choroid in suspected UES cases. This unique case also illustrated UES with thick sclera but normal microscopic scleral architecture, which was unusual. Misdiagnosis may lead to different surgical procedures such as vitrectomy resulting in unfavorable outcomes, which might have had occurred in this patient’s fellow eye.

Acknowledgements

Not applicable.
All procedures performed were in accordance with the 1964 Helsinki Declaration and its subsequent amendments or comparable ethical standards. According to guidelines and regulations of Siriraj Institutional Review Board (SIRB) the approval from local Ethical Committee is not required for a single case report.
The written informed consent was obtained from the patient for publication of this case report and any accompanying images.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Brockhurst RJ. Nanophthalmos with uveal effusion. A new clinical entity. Arch Ophthalmol. 1975;93(12):1989–99.CrossRef Brockhurst RJ. Nanophthalmos with uveal effusion. A new clinical entity. Arch Ophthalmol. 1975;93(12):1989–99.CrossRef
2.
Zurück zum Zitat Elagouz M, Stanescu-Segall D, Jackson TL. Uveal effusion syndrome. Surv Ophthalmol. 2010;55(2):134–45.CrossRef Elagouz M, Stanescu-Segall D, Jackson TL. Uveal effusion syndrome. Surv Ophthalmol. 2010;55(2):134–45.CrossRef
3.
Zurück zum Zitat Gass JD, Jallow S. Idiopathic serous detachment of the choroid, ciliary body, and retina (uveal effusion syndrome). Ophthalmology. 1982;89(9):1018–32.CrossRef Gass JD, Jallow S. Idiopathic serous detachment of the choroid, ciliary body, and retina (uveal effusion syndrome). Ophthalmology. 1982;89(9):1018–32.CrossRef
4.
Zurück zum Zitat Schepens CL, Brockhurst RJ. Uveal effusion. 1. Clinical picture. Arch Ophthalmol. 1963;70:189–201.CrossRef Schepens CL, Brockhurst RJ. Uveal effusion. 1. Clinical picture. Arch Ophthalmol. 1963;70:189–201.CrossRef
5.
Zurück zum Zitat Olsen TW, Aaberg SY, Geroski DH, Edelhauser HF. Human sclera: thickness and surface area. Am J Ophthalmol. 1998;125(2):237–41.CrossRef Olsen TW, Aaberg SY, Geroski DH, Edelhauser HF. Human sclera: thickness and surface area. Am J Ophthalmol. 1998;125(2):237–41.CrossRef
6.
Zurück zum Zitat Gass JD. Uveal effusion syndrome. A new hypothesis concerning pathogenesis and technique of surgical treatment. Retina. 1983;3(3):159–63.CrossRef Gass JD. Uveal effusion syndrome. A new hypothesis concerning pathogenesis and technique of surgical treatment. Retina. 1983;3(3):159–63.CrossRef
7.
Zurück zum Zitat Forrester JV, Lee WR, Kerr PR, Dua HS. The uveal effusion syndrome and trans-scleral flow. Eye (Lond). 1990;4(2):354–65.CrossRef Forrester JV, Lee WR, Kerr PR, Dua HS. The uveal effusion syndrome and trans-scleral flow. Eye (Lond). 1990;4(2):354–65.CrossRef
8.
Zurück zum Zitat Uyama M, Takahashi K, Kozaki J, Tagami N, Takada Y, Ohkuma H, et al. Uveal effusion syndrome: clinical features, surgical treatment, histologic examination of the sclera, and pathophysiology. Ophthalmology. 2000;107(3):441–9.CrossRef Uyama M, Takahashi K, Kozaki J, Tagami N, Takada Y, Ohkuma H, et al. Uveal effusion syndrome: clinical features, surgical treatment, histologic examination of the sclera, and pathophysiology. Ophthalmology. 2000;107(3):441–9.CrossRef
9.
Zurück zum Zitat Jackson TL, Hussain A, Morley AM, Sullivan PM, Hodgetts A, El-Osta A, et al. Scleral hydraulic conductivity and macromolecular diffusion in patients with uveal effusion syndrome. Invest Ophthalmol Vis Sci. 2008;49(11):5033–40.CrossRef Jackson TL, Hussain A, Morley AM, Sullivan PM, Hodgetts A, El-Osta A, et al. Scleral hydraulic conductivity and macromolecular diffusion in patients with uveal effusion syndrome. Invest Ophthalmol Vis Sci. 2008;49(11):5033–40.CrossRef
10.
Zurück zum Zitat Ruskell GL. Peripapillary venous drainage from the choroid: a variable feature in human eyes. Br J Ophthalmol. 1997;81(1):76–9.CrossRef Ruskell GL. Peripapillary venous drainage from the choroid: a variable feature in human eyes. Br J Ophthalmol. 1997;81(1):76–9.CrossRef
Metadaten
Titel
Unusual non-nanophthalmic uveal effusion syndrome with histologically normal scleral architecture: a case report
verfasst von
Kasama Kaewsangthong
Somanus Thoongsuwan
Mongkol Uiprasertkul
Nopasak Phasukkijwatana
Publikationsdatum
01.12.2020
Verlag
BioMed Central
Erschienen in
BMC Ophthalmology / Ausgabe 1/2020
Elektronische ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-020-01581-z

Weitere Artikel der Ausgabe 1/2020

BMC Ophthalmology 1/2020 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.